Do analysts rate TACT or EBON?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score TransAct Technologies 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Ebang International 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has higher valuation & earnings, TACT or EBON?

TransAct Technologies has higher revenue and earnings than Ebang International. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio TransAct Technologies $51.48M 1.03 -$1.24M -$0.04 N/A Ebang International $6.54M 2.13 -$14.09M N/A N/A

Do analysts prefer EBON or VTIX?

Virtuix has a consensus price target of $11.00, indicating a potential upside of 824.37%. Given Virtuix's stronger consensus rating and higher possible upside, analysts plainly believe Virtuix is more favorable than Ebang International. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ebang International 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Virtuix 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has better earnings & valuation, EBON or VTIX?

Ebang International has higher revenue and earnings than Virtuix. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Ebang International $6.54M 2.13 -$14.09M N/A N/A Virtuix $4.25M 8.39 -$16.80M -$0.70 N/A

Is EBON or VTIX more profitable?

Company Net Margins Return on Equity Return on Assets Ebang International N/A N/A N/A Virtuix N/A N/A N/A

Do analysts recommend EBON or FOXX?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ebang International 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Foxx Development 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has stronger valuation and earnings, EBON or FOXX?

Foxx Development has higher revenue and earnings than Ebang International. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Ebang International $6.54M 2.13 -$14.09M N/A N/A Foxx Development $65.92M 0.27 -$9.02M -$6.87 N/A

Is EBON or FOXX more profitable?

Ebang International has a net margin of 0.00% compared to Foxx Development's net margin of -79.80%. Company Net Margins Return on Equity Return on Assets Ebang International N/A N/A N/A Foxx Development -79.80% N/A -59.35%

Do analysts rate EBON or QCLS?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ebang International 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Mymd Pharmaceuticals 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has higher valuation and earnings, EBON or QCLS?

Mymd Pharmaceuticals has lower revenue, but higher earnings than Ebang International. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Ebang International $6.54M 2.13 -$14.09M N/A N/A Mymd Pharmaceuticals N/A N/A -$11.63M -$3.48 N/A

Is EBON or QCLS more profitable?

Ebang International's return on equity of 0.00% beat Mymd Pharmaceuticals' return on equity. Company Net Margins Return on Equity Return on Assets Ebang International N/A N/A N/A Mymd Pharmaceuticals N/A -91.64% -47.48%

Do analysts recommend EBON or AIMD?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ebang International 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Ainos 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has better valuation and earnings, EBON or AIMD?

Ebang International has higher revenue and earnings than Ainos. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Ebang International $6.54M 2.13 -$14.09M N/A N/A Ainos $120K 89.79 -$14.77M -$2.52 N/A

Ebang International (EBON) Competitors

$2.13 -0.03 (-1.34%)

As of 09/21/2026 03:17 PM Eastern

Compare

EBON vs. TACT, VTIX, FOXX, QCLS, and AIMD

Should you buy Ebang International stock or one of its competitors? Ebang International's main competitors and comparable companies include TransAct Technologies (TACT), Virtuix (VTIX), Foxx Development (FOXX), Mymd Pharmaceuticals (QCLS), and Ainos (AIMD). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "technology hardware, storage & peripherals" industry.

How does Ebang International compare to TransAct Technologies?

TransAct Technologies (NASDAQ:TACT) and Ebang International (NASDAQ:EBON) are both small-cap technology companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, media sentiment, earnings, dividends, risk, institutional ownership, profitability and valuation.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
TransAct Technologies	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Ebang International	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

74.5% of TransAct Technologies shares are owned by institutional investors. Comparatively, 1.2% of Ebang International shares are owned by institutional investors. 19.2% of TransAct Technologies shares are owned by insiders. Comparatively, 25.4% of Ebang International shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

TransAct Technologies has a beta of 1.22, indicating that its stock price is 22% more volatile than the broader market. Comparatively, Ebang International has a beta of 2.99, indicating that its stock price is 199% more volatile than the broader market.

TransAct Technologies has higher revenue and earnings than Ebang International.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
TransAct Technologies	$51.48M	1.03	-$1.24M	-$0.04	N/A
Ebang International	$6.54M	2.13	-$14.09M	N/A	N/A

Ebang International has a net margin of 0.00% compared to TransAct Technologies' net margin of -0.75%. Ebang International's return on equity of 0.00% beat TransAct Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
TransAct Technologies	-0.75%	-1.25%	-0.85%
Ebang International	N/A	N/A	N/A

In the previous week, TransAct Technologies had 3 more articles in the media than Ebang International. MarketBeat recorded 3 mentions for TransAct Technologies and 0 mentions for Ebang International. TransAct Technologies' average media sentiment score of 0.22 beat Ebang International's score of 0.00 indicating that TransAct Technologies is being referred to more favorably in the media.

Company	Overall Sentiment
TransAct Technologies	Neutral
Ebang International	Neutral

Summary

TransAct Technologies and Ebang International tied by winning 6 of the 12 factors compared between the two stocks.

How does Ebang International compare to Virtuix?

Ebang International (NASDAQ:EBON) and Virtuix (NASDAQ:VTIX) are both small-cap technology companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, valuation, institutional ownership, risk, profitability, earnings, media sentiment and analyst recommendations.

Virtuix has a consensus price target of $11.00, indicating a potential upside of 824.37%. Given Virtuix's stronger consensus rating and higher possible upside, analysts plainly believe Virtuix is more favorable than Ebang International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ebang International	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Virtuix	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Ebang International has higher revenue and earnings than Virtuix.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ebang International	$6.54M	2.13	-$14.09M	N/A	N/A
Virtuix	$4.25M	8.39	-$16.80M	-$0.70	N/A

1.2% of Ebang International shares are owned by institutional investors. 25.4% of Ebang International shares are owned by insiders. Comparatively, 28.6% of Virtuix shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Virtuix had 9 more articles in the media than Ebang International. MarketBeat recorded 9 mentions for Virtuix and 0 mentions for Ebang International. Virtuix's average media sentiment score of 0.50 beat Ebang International's score of 0.00 indicating that Virtuix is being referred to more favorably in the news media.

Company	Overall Sentiment
Ebang International	Neutral
Virtuix	Positive

Company	Net Margins	Return on Equity	Return on Assets
Ebang International	N/A	N/A	N/A
Virtuix	N/A	N/A	N/A

Summary

Virtuix beats Ebang International on 7 of the 10 factors compared between the two stocks.

How does Ebang International compare to Foxx Development?

Ebang International (NASDAQ:EBON) and Foxx Development (NASDAQ:FOXX) are both small-cap technology companies, but which is the better stock? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, profitability, earnings, media sentiment, valuation, risk and dividends.

Ebang International has a beta of 2.99, indicating that its stock price is 199% more volatile than the broader market. Comparatively, Foxx Development has a beta of -0.35, indicating that its stock price is 135% less volatile than the broader market.

Foxx Development has higher revenue and earnings than Ebang International.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ebang International	$6.54M	2.13	-$14.09M	N/A	N/A
Foxx Development	$65.92M	0.27	-$9.02M	-$6.87	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ebang International	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Foxx Development	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Ebang International's average media sentiment score of 0.00 equaled Foxx Development'saverage media sentiment score.

Company	Overall Sentiment
Ebang International	Neutral
Foxx Development	Neutral

Ebang International has a net margin of 0.00% compared to Foxx Development's net margin of -79.80%.

Company	Net Margins	Return on Equity	Return on Assets
Ebang International	N/A	N/A	N/A
Foxx Development	-79.80%	N/A	-59.35%

1.2% of Ebang International shares are owned by institutional investors. Comparatively, 60.4% of Foxx Development shares are owned by institutional investors. 25.4% of Ebang International shares are owned by insiders. Comparatively, 31.6% of Foxx Development shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

Ebang International and Foxx Development tied by winning 4 of the 8 factors compared between the two stocks.

How does Ebang International compare to Mymd Pharmaceuticals?

Ebang International (NASDAQ:EBON) and Mymd Pharmaceuticals (NASDAQ:QCLS) are both small-cap technology companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, media sentiment, risk, profitability, dividends and earnings.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ebang International	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Mymd Pharmaceuticals	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Mymd Pharmaceuticals had 24 more articles in the media than Ebang International. MarketBeat recorded 24 mentions for Mymd Pharmaceuticals and 0 mentions for Ebang International. Ebang International's average media sentiment score of 0.00 equaled Mymd Pharmaceuticals'average media sentiment score.

Company	Overall Sentiment
Ebang International	Neutral
Mymd Pharmaceuticals	Neutral

1.2% of Ebang International shares are owned by institutional investors. Comparatively, 9.6% of Mymd Pharmaceuticals shares are owned by institutional investors. 25.4% of Ebang International shares are owned by insiders. Comparatively, 0.9% of Mymd Pharmaceuticals shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Ebang International's return on equity of 0.00% beat Mymd Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Ebang International	N/A	N/A	N/A
Mymd Pharmaceuticals	N/A	-91.64%	-47.48%

Mymd Pharmaceuticals has lower revenue, but higher earnings than Ebang International.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ebang International	$6.54M	2.13	-$14.09M	N/A	N/A
Mymd Pharmaceuticals	N/A	N/A	-$11.63M	-$3.48	N/A

Ebang International has a beta of 2.99, suggesting that its share price is 199% more volatile than the broader market. Comparatively, Mymd Pharmaceuticals has a beta of 2.09, suggesting that its share price is 109% more volatile than the broader market.

Summary

Ebang International beats Mymd Pharmaceuticals on 5 of the 8 factors compared between the two stocks.

How does Ebang International compare to Ainos?

Ebang International (NASDAQ:EBON) and Ainos (NASDAQ:AIMD) are both small-cap technology companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, risk, institutional ownership, dividends, profitability, earnings, valuation and media sentiment.

Ebang International has a beta of 2.99, suggesting that its share price is 199% more volatile than the broader market. Comparatively, Ainos has a beta of 2.47, suggesting that its share price is 147% more volatile than the broader market.

1.2% of Ebang International shares are owned by institutional investors. 25.4% of Ebang International shares are owned by insiders. Comparatively, 9.8% of Ainos shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Ebang International has higher revenue and earnings than Ainos.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ebang International	$6.54M	2.13	-$14.09M	N/A	N/A
Ainos	$120K	89.79	-$14.77M	-$2.52	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ebang International	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Ainos	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Ainos had 1 more articles in the media than Ebang International. MarketBeat recorded 1 mentions for Ainos and 0 mentions for Ebang International. Ainos' average media sentiment score of 0.15 beat Ebang International's score of 0.00 indicating that Ainos is being referred to more favorably in the news media.

Company	Overall Sentiment
Ebang International	Neutral
Ainos	Neutral

Ebang International has a net margin of 0.00% compared to Ainos' net margin of -11,912.10%. Ebang International's return on equity of 0.00% beat Ainos' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Ebang International	N/A	N/A	N/A
Ainos	-11,912.10%	-217.50%	-67.87%

Summary

Ebang International beats Ainos on 8 of the 11 factors compared between the two stocks.

Get Ebang International News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding EBON and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

EBON vs. The Competition

Export

Metric	Ebang International	Technology Hardware, Storage & Peripherals Industry	Technology Sector	NASDAQ Exchange
Market Cap	$14.14M	$121.21B	$30.33B	$12.97B
Dividend Yield	N/A	1.62%	2.75%	12.80%
P/E Ratio	N/A	28.57	78.43	25.77
Price / Sales	2.13	91.15	590.19	109.69
Price / Cash	N/A	21.44	46.90	34.72
Price / Book	0.06	8.26	7.96	6.36
Net Income	-$14.09M	$3.49B	$701.04M	$358.17M
7 Day Performance	6.55%	6.73%	2.33%	1.60%
1 Month Performance	-8.15%	-3.00%	-1.68%	-2.97%
1 Year Performance	-57.38%	59.79%	176.50%	5.63%

Ebang International Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
EBON Ebang International	0.3926 of 5 stars	$2.13 -1.3%	N/A	-57.9%	$14.14M	$6.54M	N/A	197	High Trading Volume
TACT TransAct Technologies	1.1429 of 5 stars	$5.40 +3.1%	N/A	+6.6%	$54.10M	$52.99M	N/A	120	News Coverage
VTIX Virtuix	1.9877 of 5 stars	$1.14 -9.5%	$11.00 +864.9%	N/A	$37.76M	$4.25M	N/A	39
FOXX Foxx Development	0.7114 of 5 stars	$2.71 +4.2%	N/A	-49.2%	$18.27M	$65.92M	N/A	N/A	Positive News
QCLS Mymd Pharmaceuticals	0.1827 of 5 stars	$1.78 -7.8%	N/A	N/A	$15.81M	N/A	N/A	6	Analyst Upgrade Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:EBON) was last updated on 9/22/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Ebang International (EBON) Competitors

EBON vs. TACT, VTIX, FOXX, QCLS, and AIMD

How does Ebang International compare to TransAct Technologies?

Summary

How does Ebang International compare to Virtuix?

Summary

How does Ebang International compare to Foxx Development?

Summary

How does Ebang International compare to Mymd Pharmaceuticals?

Summary

How does Ebang International compare to Ainos?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

EBON vs. The Competition

Ebang International Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Ebang International (EBON) Competitors

EBON vs. TACT, VTIX, FOXX, QCLS, and AIMD

How does Ebang International compare to TransAct Technologies?

Do analysts rate TACT or EBON?

Do insiders & institutionals believe in TACT or EBON?

Which has more risk & volatility, TACT or EBON?

Which has higher valuation & earnings, TACT or EBON?

Is TACT or EBON more profitable?

Does the media prefer TACT or EBON?

Summary

How does Ebang International compare to Virtuix?

Do analysts prefer EBON or VTIX?

Which has better earnings & valuation, EBON or VTIX?

Do institutionals & insiders believe in EBON or VTIX?

Does the media prefer EBON or VTIX?

Is EBON or VTIX more profitable?

Summary

How does Ebang International compare to Foxx Development?

Which has more volatility and risk, EBON or FOXX?

Which has stronger valuation and earnings, EBON or FOXX?

Do analysts recommend EBON or FOXX?

Does the media prefer EBON or FOXX?

Is EBON or FOXX more profitable?

Do insiders & institutionals have more ownership in EBON or FOXX?

Summary

How does Ebang International compare to Mymd Pharmaceuticals?

Do analysts rate EBON or QCLS?

Does the media prefer EBON or QCLS?

Do insiders & institutionals have more ownership in EBON or QCLS?

Is EBON or QCLS more profitable?

Which has higher valuation and earnings, EBON or QCLS?

Which has more volatility and risk, EBON or QCLS?

Summary

How does Ebang International compare to Ainos?

Which has more risk & volatility, EBON or AIMD?

Do insiders & institutionals have more ownership in EBON or AIMD?

Which has better valuation and earnings, EBON or AIMD?

Do analysts recommend EBON or AIMD?

Does the media favor EBON or AIMD?

Is EBON or AIMD more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

EBON vs. The Competition

Ebang International Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools